QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
OTCMKTS:NICXF

Nicox (NICXF) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free NICXF Stock Alerts
$0.44
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.44
▼
$0.44
50-Day Range
$0.44
▼
$0.44
52-Week Range
$0.44
▼
$0.44
Volume
N/A
Average Volume
N/A
Market Capitalization
$22.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlinesShort Interest
NICXF stock logo

About Nicox Stock (OTCMKTS:NICXF)

Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial. The company is also developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals that is in Phase 2b clinical trial for the treatment of dry eye disease; and NCX 1728, an NO-donating Phosphodiesterase-5 inhibitor, which is in preclinical evaluation. It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was incorporated in 1996 and is headquartered in Valbonne, France.

NICXF Stock Price History

NICXF Stock News Headlines

March 27, 2024 | yahoo.com
Comical Psychosomatic Medicine Season 1 Streaming: Watch & Stream Online via Crunchyroll
March 9, 2024 | msn.com
The Perfect Prince Loves Me, the Side Character?! anime unwraps its charms on March 15
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
February 23, 2024 | msn.com
How to Read the Entire Bleach Manga Online in 2024?
February 21, 2024 | finance.yahoo.com
Japan OTT and Pay TV Sector Forecasts to 2029: In-depth Analysis of Market Trends and Revenue Opportunities
February 1, 2024 | msn.com
AnimeFesta's boys love Series, 'The Perfect Prince Loves Me, His Rival?!,' reveals cast and visuals
January 19, 2024 | yahoo.com
Julia Michaels Talks ‘Surreal’ Experience Writing Music for Disney’s ‘Wish’
January 19, 2024 | yahoo.com
Michael Jackson’s Nephew Jaafar Jackson Shares Toe Stand Photo Portraying the Icon in Biopic
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
January 19, 2024 | msn.com
Celebrating Saudi Creativity: Swizz Beatz on His Deep Connection to the Kingdom
January 19, 2024 | yahoo.com
12 Albums, 12 Stories: Elissa Revisits the Milestones of Her Journey as the Arab World’s ‘Queen of Emotions’
January 19, 2024 | msn.com
Yukopi Rules Billboard Japan’s ‘NICONICO VOCALOID SONGS TOP20’ Year-End Chart: A Look Back at the 2023 Vocaloid Scene
January 12, 2024 | finance.yahoo.com
Nicox S.A. (ALCOX.PA)
January 3, 2024 | msn.com
Japan 2011 tsunami clip falsely shared as damage from New Year's Day quake
January 3, 2024 | msn.com
Where To Watch The FF14 Japan Fan Fest 2024
December 18, 2023 | markets.businessinsider.com
Nicox Announces First Patient Screened in the Whistler Phase 3b Trial of NCX 470 in Glaucoma
December 14, 2023 | finance.yahoo.com
Nicox’s Announces Publication of New Nonclinical Data Demonstrating More Effective Intraocular Pressure Lowering of NCX 470 compared to Lumigan
December 2, 2023 | morningstar.com
Nicox SA Share from reverse split ALCOX
November 26, 2023 | msn.com
‘Jujutsu Kaisen’ Singer Eve’s First Asia Tour 2024 Has Singapore As Second Stop
November 13, 2023 | msn.com
Does I Shall Survive Using Potions anime have a manga? Explained
November 11, 2023 | msn.com
10 Best Pokémon Anime Openings, Ranked
November 7, 2023 | msn.com
Nicox SA (NICXF) Upgraded to Buy: Here's What You Should Know
October 20, 2023 | msn.com
Nicox reports Q3 results
October 20, 2023 | markets.businessinsider.com
Nicox Provides First Half 2023 and Third Quarter 2023 Financial Results and Updates Key Milestones
October 7, 2023 | nasdaq.com
Nicox (PAR:ALCOX) Price Target Increased by 5.26% to 3.06
July 19, 2023 | benzinga.com
Nicox Provides Second Quarter 2023 Financial and Business Highlights
July 10, 2023 | finance.yahoo.com
Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million
See More Headlines
Receive NICXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nicox and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:NICXF
Previous Symbol
NASDAQ:NICXF
CUSIP
N/A
CIK
N/A
Web
www.nicox.com
Phone
(349) 724-5300
Fax
33-4-97-24-53-99
Employees
28
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$5.52 million
Price / Sales
3.99
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.10 per share
Price / Book
0.40

Miscellaneous

Outstanding Shares
50,100,000
Free Float
N/A
Market Cap
$22.04 million
Optionable
Not Optionable
Beta
0.36
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Michele Garufi Ph.D. (Age 70)
    Co-Founder & Director
    Comp: $471.16k
  • Dr. Gavin M. Spencer (Age 54)
    Chief Executive Officer
  • Ms. Sandrine Gestin (Age 57)
    Vice President of Finance
  • Mr. Doug Hubatsch (Age 57)
    Executive VP & Chief Scientific Officer
  • Dr. Ramesh Krishnamoorthy
    Senior Director and Head of Late Stage CMC & Quality Control
  • Dr. Jose Boyer
    Consultant

Key Competitors

View All Competitors

NICXF Stock Analysis - Frequently Asked Questions

How have NICXF shares performed in 2024?

Nicox's stock was trading at $0.44 at the beginning of the year. Since then, NICXF shares have increased by 0.0% and is now trading at $0.44.
View the best growth stocks for 2024 here.

How do I buy shares of Nicox?

Shares of NICXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NICXF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media